Rankings
▼
Calendar
ANNX
Annexon, Inc.
$706M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$271,000
Operating Income
-$20M
Net Income
-$19M
EPS (Diluted)
$-0.49
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$401,000
Balance Sheet
Total Assets
$8M
Total Liabilities
$54M
Stockholders' Equity
-$46M
Cash & Equivalents
$3M
← Q1 2018
All Quarters
ANNX FY 2017 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
